The societal impact of inclisiran in England: Evidence from a population health approach

As first-in-class cholesterol-lowering small interfering ribonucleic acid (siRNA), inclisiran provides effective reductions in low-density lipoprotein cholesterol (LDL-C) to achieve better cardiovascular (CV) health. We estimate health and socioeconomic effects, of introducing inclisiran according to a population health agreement in England.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research